S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
China Threat Triggers Potential Mining Boom for Investors (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
Are the Short Sellers Still Right About Mullen Automotive stock? 
China Threat Triggers Potential Mining Boom for Investors (Ad)
La-Z-Boy Reclines To More Comfortable Levels 
Is The Recovery Rally Here For SoFi?
China Threat Triggers Potential Mining Boom for Investors (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
China Threat Triggers Potential Mining Boom for Investors (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
Are the Short Sellers Still Right About Mullen Automotive stock? 
China Threat Triggers Potential Mining Boom for Investors (Ad)
La-Z-Boy Reclines To More Comfortable Levels 
Is The Recovery Rally Here For SoFi?
China Threat Triggers Potential Mining Boom for Investors (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
China Threat Triggers Potential Mining Boom for Investors (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
Are the Short Sellers Still Right About Mullen Automotive stock? 
China Threat Triggers Potential Mining Boom for Investors (Ad)
La-Z-Boy Reclines To More Comfortable Levels 
Is The Recovery Rally Here For SoFi?
China Threat Triggers Potential Mining Boom for Investors (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
China Threat Triggers Potential Mining Boom for Investors (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
Are the Short Sellers Still Right About Mullen Automotive stock? 
China Threat Triggers Potential Mining Boom for Investors (Ad)
La-Z-Boy Reclines To More Comfortable Levels 
Is The Recovery Rally Here For SoFi?
China Threat Triggers Potential Mining Boom for Investors (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
NASDAQ:AVAH

Aveanna Healthcare - AVAH Stock Forecast, Price & News

$0.76
+0.08 (+11.85%)
(As of 12/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.67
$0.77
50-Day Range
$0.68
$1.69
52-Week Range
$0.67
$7.53
Volume
2.43 million shs
Average Volume
419,948 shs
Market Capitalization
$140.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.25

Aveanna Healthcare MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
330.3% Upside
$3.25 Price Target
Short Interest
Bearish
4.40% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.62mentions of Aveanna Healthcare in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.89 out of 5 stars

Medical Sector

352nd out of 1,047 stocks

Home Health Care Services Industry

5th out of 9 stocks

AVAH stock logo

About Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Receive AVAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aveanna Healthcare and its competitors with MarketBeat's FREE daily newsletter.

AVAH Stock News Headlines

4 Analysts Have This to Say About Aveanna Healthcare Hldgs
What 4 Analyst Ratings Have To Say About Aveanna Healthcare Hldgs
Aveanna cut to Neutral at Credit Suisse on weak Q3 show
AVAH Aveanna Healthcare Holdings Inc.
Amedisys (AMED) Misses Q3 Earnings and Revenue Estimates
Chicago Health Care News
Milwaukee Health Care News
Where Aveanna Healthcare Hldgs Stands With Analysts
Aveanna Healthcare Holdings Announces Second-...
Aveanna: Q2 Earnings Snapshot
Aveanna Healthcare Earnings Outlook
See More Headlines
Receive AVAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aveanna Healthcare and its competitors with MarketBeat's FREE daily newsletter.

AVAH Company Calendar

Last Earnings
11/09/2022
Today
12/02/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/27/2023

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AVAH
Fax
N/A
Employees
33,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$3.25
High Stock Price Forecast
$6.00
Low Stock Price Forecast
$1.25
Forecasted Upside/Downside
+330.3%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
9 Analysts

Profitability

Net Income
$-117,040,000.00
Pretax Margin
-31.24%

Debt

Sales & Book Value

Annual Sales
$1.68 billion
Cash Flow
$1.35 per share
Book Value
$1.23 per share

Miscellaneous

Free Float
169,929,000
Market Cap
$140.41 million
Optionable
Not Optionable
Beta
0.91

Key Executives

  • Mr. Rodney D. Windley (Age 74)
    Exec. Chairman
    Comp: $1.5M
  • Mr. Tony StrangeMr. Tony Strange (Age 59)
    CEO & Director
    Comp: $1.5M
  • Mr. David Afshar CPAMr. David Afshar CPA (Age 49)
    Chief Financial Officer
    Comp: $701.4k
  • Mr. Jeffrey ShanerMr. Jeffrey Shaner (Age 49)
    Chief Operating Officer
    Comp: $964.25k
  • Mr. Shannon L. Drake (Age 46)
    Gen. Counsel & Chief Legal Officer
    Comp: $601.31k
  • Mr. Ed Reisz (Age 63)
    Chief Admin. Officer
  • Mr. Patrick A. Cunningham (Age 66)
    Chief Compliance Officer
  • Ms. Beth Rubio (Age 65)
    Chief Clinical Officer
  • Ms. Korey Hinz
    Pres of Medical Solutions
  • Mr. Robert Radics
    Pres of Home Health & Hospice













AVAH Stock - Frequently Asked Questions

Should I buy or sell Aveanna Healthcare stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aveanna Healthcare in the last year. There are currently 1 sell rating, 5 hold ratings, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AVAH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AVAH, but not buy additional shares or sell existing shares.
View AVAH analyst ratings
or view top-rated stocks.

What is Aveanna Healthcare's stock price forecast for 2023?

9 equities research analysts have issued 1-year price targets for Aveanna Healthcare's shares. Their AVAH share price forecasts range from $1.25 to $6.00. On average, they predict the company's stock price to reach $3.25 in the next year. This suggests a possible upside of 330.3% from the stock's current price.
View analysts price targets for AVAH
or view top-rated stocks among Wall Street analysts.

How have AVAH shares performed in 2022?

Aveanna Healthcare's stock was trading at $7.40 on January 1st, 2022. Since then, AVAH stock has decreased by 89.8% and is now trading at $0.7552.
View the best growth stocks for 2022 here
.

When is Aveanna Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 27th 2023.
View our AVAH earnings forecast
.

How were Aveanna Healthcare's earnings last quarter?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) posted its quarterly earnings data on Wednesday, November, 9th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.04 by $0.07. The business had revenue of $443.01 million for the quarter, compared to analysts' expectations of $448.84 million. Aveanna Healthcare had a positive trailing twelve-month return on equity of 6.05% and a negative net margin of 31.44%.

What guidance has Aveanna Healthcare issued on next quarter's earnings?

Aveanna Healthcare issued an update on its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.78B-, compared to the consensus revenue estimate of $1.80 billion.

When did Aveanna Healthcare IPO?

(AVAH) raised $478 million in an initial public offering on Thursday, April 29th 2021. The company issued 38,200,000 shares at a price of $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse served as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers.

What is Aveanna Healthcare's stock symbol?

Aveanna Healthcare trades on the NASDAQ under the ticker symbol "AVAH."

Who are Aveanna Healthcare's major shareholders?

Aveanna Healthcare's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vaughan Nelson Investment Management L.P. (2.70%), Littlejohn & Co. LLC (2.23%), Vanguard Group Inc. (1.83%), BlackRock Inc. (1.75%), LGT Capital Partners LTD. (0.91%) and Putnam Investments LLC (0.64%). Insiders that own company stock include David Afshar, Jeff Shaner, Patrick A Cunningham, Steven E Rodgers and Tony Strange.
View institutional ownership trends
.

How do I buy shares of Aveanna Healthcare?

Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aveanna Healthcare's stock price today?

One share of AVAH stock can currently be purchased for approximately $0.76.

How much money does Aveanna Healthcare make?

Aveanna Healthcare (NASDAQ:AVAH) has a market capitalization of $140.41 million and generates $1.68 billion in revenue each year. The company earns $-117,040,000.00 in net income (profit) each year or ($2.97) on an earnings per share basis.

How many employees does Aveanna Healthcare have?

The company employs 33,000 workers across the globe.

How can I contact Aveanna Healthcare?

Aveanna Healthcare's mailing address is 400 INTERSTATE NORTH PARKWAY STE 1700, ATLANTA GA, 30339. The official website for the company is www.aveanna.com. The company can be reached via phone at 770-441-1580 or via email at ir@aveanna.com.

This page (NASDAQ:AVAH) was last updated on 12/2/2022 by MarketBeat.com Staff